周一（8月4日）盘中，生物制药公司TG Therapeutics Inc.（TGTX）股价大幅下挫，跌幅高达13.45%，引发市场广泛关注。这一显著跌幅出现在公司即将公布第二季度财报之际，反映出投资者对公司业绩的担忧情绪正在加剧。
根据公司此前安排，TG Therapeutics将于周一（8月4日）早上7:00公布2025年第二季度财报。分析师平均预期公司每股盈利（EPS）为0.21美元。然而，在财报公布前夕，投资者似乎对公司的业绩表现产生了疑虑，导致股价出现大幅下跌。
市场分析人士指出，这种在财报公布前的剧烈股价波动可能反映了投资者对公司业绩可能不及预期的担忧。部分投资者可能选择在财报公布前提前卖出股票以规避潜在风险。此外，生物制药行业的高度不确定性也可能加剧了市场的紧张情绪。投资者现在将密切关注TG Therapeutics的财报内容，以评估公司的实际经营状况和未来发展前景。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.